The fog you feel is not abstract. It is not psychological. And it is not located somewhere vague in "the brain."

It is happening in specific cells, in specific regions, through specific biochemical processes that researchers can now identify, measure, and in many cases, target. Since 2022, a series of landmark studies — published in Cell, Neuron, and Nature Neuroscience — have mapped exactly what COVID-19 does to the brain's individual cell populations.

What they found is striking, and in some ways counterintuitive: the virus does not need to infect brain cells directly to cause serious, lasting neurological damage. The damage — including loss of the cells responsible for maintaining the brain's communication infrastructure — can result from the immune response alone, even after a mild respiratory infection.

If you've read Article 1 on COVID brain fog generally and Article 2 on memory loss specifically, this article goes a level deeper — into the individual cell types responsible for the cognitive impairment those articles described.

The Brain Is Not a Single Thing — It's a Community of Cell Types

Most people think of brain damage in terms of neurons — the nerve cells that carry signals. But neurons represent only a fraction of the brain's cell population. The human brain contains approximately 86 billion neurons — but also roughly 85 billion non-neuronal cells, including the immune cells, support cells, and structural cells that make neural function possible. COVID-19 disrupts multiple cell types simultaneously, which is why its cognitive effects are so broad and so persistent.

Microglia: The Immune Cells That Won't Stand Down

Microglia are the brain's resident immune cells — its first and most powerful line of defense against infection and injury. Under normal conditions, they perform essential maintenance functions: clearing cellular debris, pruning unnecessary synapses, and monitoring for threats. They are exquisitely sensitive — and therein lies the problem with COVID-19.

When COVID-19 triggers a systemic inflammatory response, microglia become activated — shifting from their normal surveillance mode into a reactive, inflammatory state. The landmark 2022 study published in Cell by Fernández-Castañeda and colleagues (Stanford, Yale, and Mount Sinai) found that even mild, respiratory-system-restricted COVID-19 caused prominent, selective microglial reactivity in the brain's white matter — without the virus ever directly infecting brain cells.

The microglial activation is driven by inflammatory signals — particularly the chemokine CCL11 (eotaxin) — that travel from the infected respiratory system through the bloodstream and into the brain. Once activated, microglia in the reactive state begin causing collateral damage to the very cells they are meant to protect.

Oligodendrocytes: The Myelin Makers Under Attack

Oligodendrocytes are the cells responsible for producing and maintaining myelin — the insulating sheath that wraps around nerve fibers and enables rapid, efficient signal transmission. Think of myelin as the insulation around electrical wires. Without it, signals travel slowly or not at all.

The Fernández-Castañeda Cell study found that activated microglia — triggered by the inflammatory response to COVID — directly impaired the generation of oligodendrocyte lineage cells and disrupted myelin plasticity: the brain's capacity to adapt and repair myelin in response to neural activity. The result was a distributed loss of myelinated axons throughout white matter — not the focal, plaque-like demyelination seen in multiple sclerosis, but a diffuse reduction in white matter integrity that directly impairs the speed and efficiency of neural communication.

This is a plausible direct explanation for the processing slowdowns so characteristic of COVID brain fog: the brain's signal transmission infrastructure has been partially dismantled.

Why COVID Brain Fog Resembles "Chemo Brain" — and What That Tells Us

One of the most significant findings in the Fernández-Castañeda Cell paper was not what COVID does to the brain — it was what it resembles.

The researchers noted that Long COVID's cognitive syndrome shares striking similarities with cancer therapy-related cognitive impairment (CRCI) — commonly known as "chemo brain." Both conditions involve: white-matter-selective microglial reactivity, loss of oligodendrocytes and myelinated axons, suppressed hippocampal neurogenesis, and elevated CCL11. Both produce similar patterns of memory impairment, processing slowdowns, and fatigue-sensitive cognitive function.

Feature	COVID Brain Fog	"Chemo Brain" (CRCI)
Microglial reactivity	White-matter selective ✓	White-matter selective ✓
Oligodendrocyte loss	~30% within 1 week ✓	Documented ✓
Hippocampal neurogenesis	Suppressed ✓	Suppressed ✓
CCL11 elevation	Confirmed ✓	Confirmed ✓
Cognitive profile	Memory, processing speed, fatigue	Memory, processing speed, fatigue

Astrocytes: From Support Cells to Active Saboteurs

Astrocytes are the brain's most abundant cell type, performing essential support functions: regulating synaptic signaling, managing blood flow to active brain regions, maintaining the ionic environment around neurons, and clearing neurotransmitters after use. They are the brain's infrastructure — invisible when functioning correctly, catastrophic when disrupted.

Under normal conditions, astrocytes can enter reactive states to respond to injury — a process called astrocyte reactivity. Under the neuroinflammatory conditions created by COVID-19, some astrocytes shift into a neurotoxic sub-state — in which, rather than supporting neural function, they begin actively secreting factors that damage oligodendrocytes and susceptible neurons.

This reactive astrocyte state is induced by the cytokines released by activated microglia — creating a self-amplifying inflammatory loop in which microglial activation triggers astrocyte toxicity, which further disrupts the cellular environment that microglia are attempting to protect. [Nalbandian et al., Neuron, 2022]

Neurons: Aberrant Pruning and Altered Excitability

In a healthy brain, microglia perform an important function called synaptic pruning — selectively eliminating weak or redundant synaptic connections during development and throughout adult life, to maintain efficient neural circuits. This process is essential for learning and memory formation.

In the reactive microglial state triggered by COVID-19, this pruning process becomes aberrant: microglia eliminate synapses indiscriminately, including connections that are functional and necessary. The result is a net reduction in synaptic density — a literal thinning of the neural connections that underlie memory storage, cognitive processing, and communication between brain regions.

Additionally, reactive microglia alter the excitability of neurons — changing the threshold at which they fire. This dysregulation of neural activity patterns contributes to the unpredictable cognitive performance, fluctuating symptom severity, and difficulty sustaining mental effort that characterize Long COVID.

The Full Cellular Cascade: From Infection to Cognitive Impairment

These cell-level events do not happen in isolation. They form an interconnected cascade — each disruption amplifying the next:

What Can Reverse Cellular-Level Damage? The Evidence by Cell Type

The cellular damage from COVID-19 is serious — but the brain is not a static organ. Myelin can be repaired. New oligodendrocyte precursor cells exist in the brain throughout adult life. Hippocampal neurogenesis, while suppressed, is not permanently abolished. And microglia can return to surveillance mode when the inflammatory environment that keeps them activated is reduced.

The key to cellular recovery is reducing the neuroinflammatory drive — lowering the levels of CCL11, IL-6, and other inflammatory mediators that keep microglia in their reactive state and prevent oligodendrocyte and neurogenesis recovery.

Target Cell	Recovery Mechanism	Key Interventions
Microglia	Return to surveillance mode by reducing inflammatory signaling (CCL11, IL-6, TNF-α)	Anti-inflammatory diet · Omega-3 DHA · Stress reduction · Sleep priority
Oligodendrocytes	OPC (precursor) cells in brain can differentiate into new oligodendrocytes when microglial reactivity is reduced; BDNF and irisin support maturation	Paced aerobic exercise (BDNF) · Lion's Mane (NGF) · Remyelination-supporting nutrients
Hippocampal Neurons	Adult neurogenesis can resume when inflammatory suppression is lifted; new neurons integrate into memory circuits	Restorative sleep (deep SWS) · Novel learning · Lion's Mane · DHA · Bacopa
Astrocytes	Return from neurotoxic to neuroprotective state when microglial cytokine signaling normalizes	Anti-inflammatory interventions (address microglia first; astrocyte recovery is downstream)
Endothelial (BBB)	BBB tight junction repair when inflammation is controlled; vascular health supporting agents	Pine bark extract (Pycnogenol) · Ginkgo biloba · Omega-3 · Blood pressure control

The Bottom Line

The cellular science of Long COVID is no longer speculative. A landmark 2022 study published in Cell by researchers from Stanford, Yale, and Mount Sinai demonstrated that mild COVID — without the virus entering the brain — can destroy 30% of the myelin-producing cells that underpin neural communication within a single week. This loss, combined with microglial overactivation, astrocyte toxicity, aberrant synaptic pruning, and blood-brain barrier disruption, creates a multi-cell-type disruption that directly explains the cognitive symptoms of Long COVID.

The parallel with cancer therapy-related cognitive impairment — a syndrome that has been studied for decades — provides a roadmap: the interventions that support remyelination, reduce neuroinflammation, and restore hippocampal neurogenesis in chemo brain patients have direct relevance to Long COVID recovery. The cellular damage is serious, but it is not permanent. The brain retains its capacity for repair — and the recovery interventions described in this series directly target the cellular mechanisms that make that repair possible.